Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-026288
Filing Date
2013-05-08
Accepted
2013-05-08 17:53:20
Documents
1
Period of Report
2013-05-06

Document Format Files

Seq Description Document Type Size
1 DAVE MAY 6 rrd378961.html 4  
1 DAVE MAY 6 rrd378961.xml 4 6832
  Complete submission text file 0001181431-13-026288.txt   8486
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address
DAVE KAUSHIK J (Reporting) CIK: 0001522751 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 13825853